ARAB PHARMACEUTICALSAA

ARAB PHARMACEUTICALS

171.030EGPD
−0.570−0.33%
At close at 13:07 GMT
EGP
No trades
See on Supercharts

ADCI fundamentals

Key facts

Market capitalization‪1.03 B‬EGP
Founded1964
CEO
About

Arab Pharmaceuticals engages in the manufacture, packaging, distribution and trade of drugs, pharmaceuticals, and chemicals. Its products include ampoules, tablets, syrups, solutions, capsules, aerosol sprays, metered dose inhalers, granulated powder for suspension, creams, ointments, and suppositories. The company is also involved in the purchase and sale of compounds, raw materials, and related products. Arab Pharmaceuticals was founded on November 7, 1964 and is headquartered in Cairo, Egypt.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
‪‪1.03 B‬‬
Price to earning ratio (P/E)
8.37x
Price to sales ratio (P/S)
1.11x
Market Cap
Net income
Revenue
Price to earning ratio (P/E)
8.37x
Price to sales ratio (P/S)
1.11x
Valuation ratios
‪0.00‬
‪0.25‬
‪0.50‬
‪0.75‬
‪1.00‬
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Q2 '25
‪0.00‬
‪1.70‬
‪3.40‬
‪5.10‬
‪6.80‬
P/E
P/S

Growth and Profitability

Company’s recent performance and margins

Performance
‪8.5%‬
‪11.0%‬
‪13.5%‬
‪16.0%‬
‪18.5%‬
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Q2 '25
‪0.00‬
‪‪90.00 M‬‬
‪‪180.00 M‬‬
‪‪270.00 M‬‬
‪‪360.00 M‬‬
Revenue
Net income
Net margin %
Revenue to profit conversion
Revenue
COGS
Gross profit
Op expenses
Op income
Non-Op income/ expenses
Taxes & Other
Net income
‪0.00‬
‪‪90.00 M‬‬
‪‪180.00 M‬‬
‪‪270.00 M‬‬
‪‪360.00 M‬‬
Revenue
COGS
Gross profit
Expenses & adjustments
Net income
‪0.00‬
‪‪90.00 M‬‬
‪‪180.00 M‬‬
‪‪270.00 M‬‬
‪‪360.00 M‬‬

Revenue breakdown

Revenue streams and regions a business earns money from

By source/business
Period: 2024
Pharmaceutical and Chemical Products
By country
Period: 2024
Egypt

Estimates

Revenue and Earnings forecasts and estimates accuracy

Revenue
2021
2022
2023
2024
2025
‪0.00‬
‪‪250.00 M‬‬
‪‪500.00 M‬‬
‪‪750.00 M‬‬
‪‪1.00 B‬‬
Actual
Estimate
Earnings
Next:Aug 29, 2025
2021
2022
2023
2024
2025
‪0.00‬
‪4.00‬
‪8.00‬
‪12.00‬
‪16.00‬
Actual
Estimate

Dividends

Dividend yield, history and sustainability

Dividend summary
40.73%
Earnings retained
Payout ratio (TTM)
Dividend yield TTM
4.84%
Last payment
8.35
Last ex-date
Oct 28, 2024
Last pay date
Oct 30, 2024
Dividend history
‪6.5%‬
‪7.5%‬
‪8.5%‬
‪9.5%‬
‪10.5%‬
2020
2021
2022
2023
2024
‪0.00‬
‪2.10‬
‪4.20‬
‪6.30‬
‪8.40‬
Dividends per share (FY)
Dividend yield (FY) %

Financial health

Financial position and solvency of the company

Debt level and coverage
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Q2 '25
‪‪−200.00 M‬‬
‪0.00‬
‪‪200.00 M‬‬
‪‪400.00 M‬‬
‪‪600.00 M‬‬
Debt
Free cash flow
Cash & equivalents
Financial position analysis
Short term
Long term
‪0.00‬
‪‪160.00 M‬‬
‪‪320.00 M‬‬
‪‪480.00 M‬‬
‪‪640.00 M‬‬
Assets
Liabilities